References

  1. Viviane A, Alan BN. Estimates of Costs of Hospital Stay for Variceal and Nonvariceal Upper Gastrointestinal Bleeding in the United States. Value in Health. 2008; 11(1): 1-3. PubMed | Google Scholar

  2. Cryer BL, Wilcox CM, Henk HJ et al. The economics of upper gastrointestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis. Journal of medical economics. 2010; 13(1): 70–7. PubMed | Google Scholar

  3. Nahon S, Hagège H, Latrive JP et al. Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy. 2012; 44(11): 998–1008. PubMed | Google Scholar

  4. Crooks C, Sung J, Card TR. Epidemiology of upper gastrointestinal bleeding. GI Epidemiology: Diseases and Clinical Methodology. 2013; 172. Google Scholar

  5. Roberts SE, Button LA, Williams JG. Prognosis following Upper Gastrointestinal Bleeding. PLoS ONE. 2012; 7(12): e49507. PubMed | Google Scholar

  6. Harries AD, Wirima JJ. Upper gastrointestinal bleeding in Malawian adults and value of splenomegaly in predicting source of haemorrhage. East Afr Med J. 1989; 66(2): 97–9. PubMed | Google Scholar

  7. Lule GN, Obiero ET, Ogutu EO. Factors that influence the short term outcome of upper gastrointestinal bleeding at Kenyatta National Hospital. East Afr Med J. 1994; 71(4): 240–5. PubMed | Google Scholar

  8. Alema ON, Martin DO, Okello TR. Endoscopic findings in upper gastrointestinal bleeding patients at Lacor hospital, northern Uganda. Afr Health Sci. 2012; 12(4): 518–21. PubMed | Google Scholar

  9. Suba M, Ayana SM, Mtabho CM et al. The aetiology, management and clinical outcome of upper gastrointestinal bleeding among patients admitted at the Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Tanzan J Health Res. 2010; 12(4): 302–5. PubMed | Google Scholar

  10. Boyer TD. Natural history of portal hypertension. Clinics in liver disease. 1997; 1(1): 31–44. PubMed | Google Scholar

  11. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of hepatology. 2006; 44(1): 217–31. PubMed | Google Scholar

  12. Carruthers RH, Sinha P. Bilharzial portal fibrosis: an important cause of portal hypertension. Ann R Coll Surg Engl. 1978; 60(1): 49–52. PubMed | Google Scholar

  13. Ravera M, Reggiori A, Cocozza E et al. Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda. Eur J Gastroenterol Hepatol. 1996; 8(7): 693–7. PubMed | Google Scholar

  14. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001; 5(3): 645–63. PubMed | Google Scholar

  15. Kiire CF. Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. BMJ: British Medical Journal. 1989; 298(6684): 1363. PubMed | Google Scholar

  16. Cordeiro F. Variceal sclerosis in schistosomotic patients: a 5-year follow-up study. Gastrointest Endosc. 1990; 36(5): 475–8. PubMed | Google Scholar

  17. Saad AMA, Hassan MA, Homeida M et al. Oesophageal varices in a region of the Sudan endemic for Schistosoma mansoni. British journal of surgery. 1991; 78(10): 1252–3. PubMed | Google Scholar

  18. Madwar MA, Shaker MK, Atta MA et al. A prospective study: prediction of the first variceal haemorrhage in schistosomal and non schistosomal liver disease. The Journal of the Egyptian Public Health Association. 1996; 72(3–4): 395–409. PubMed | Google Scholar

  19. Ibrahim SZ, Shah T, Arbab BM et al. Risk factors for bleeding in patients with asymptomatic oesophageal varices secondary to schistosomal portal hypertension: a longitudinal hospital based study. Sudan Med J. 2009; 45(1). Google Scholar

  20. Ibrahim ZS, Arbab MB, Suleiman HS et al. The natural history of bleeding oesophageal varices in patients with schistosomal portal hypertension. Published Online First: January 2010. http://khartoumspace.uofk.edu/handle/123456789/3963 (accessed 16 May 2015). Google Scholar

  21. Opio CK, Garcia-Tsao G. Managing varices: drugs, bands, and shunts. Gastroenterology Clinics of North America. 2011; 40(3): 561-79. PubMed | Google Scholar

  22. Kheir MM. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis. East Mediterr Health J. 2000 Sep-Nov; 6(5-6): 926-31. PubMed | Google Scholar

  23. Cleland CR, Tukahebwa EM, Fenwick A et al. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children. Trans R Soc Trop Med Hyg. 2014; 108(9): 575-81. PubMed | Google Scholar

  24. Tajiri T, Yoshida H, Obara K et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc. 2010; 22(1): 1–9. Google Scholar

  25. De Groot NL, van Oijen MGH, Kessels K et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: can classification be simplified?. Endoscopy. 2014; 46(1): 46-52. PubMed | Google Scholar

  26. Strasser R. Rural health around the world: challenges and solutions. Family Practice. 2003; 20(4): 457–63. PubMed | Google Scholar

  27. Kirigia JM, Barry SP. Health challenges in Africa and the way forward. Int Arch Med. 2008 Dec 18; 1(1): 27. PubMed | Google Scholar

  28. Organization WH. Everybody’s business: Strengthening health systems to improve health outcomes. WHO framework for action [document on the Internet]. c2007 [cited 2013 Nov 15]. Google Scholar

  29. Dworzynski K, Pollit V, Kelsey A et al. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ. 2012; 344: e3412. PubMed | Google Scholar

  30. Richter J, Correia Dacal AR, Vergetti Siqueira JG et al. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Tropical Medicine & International Health. 1998; 3(9): 728–35. PubMed | Google Scholar

  31. Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martín M. Classification of anemia for gastroenterologists. World J Gastroenterol. 2009; 15(37): 4627-37. PubMed | Google Scholar

  32. Lambertucci JR. Revisiting the concept of hepatosplenic schistosomiasis and its challenges using traditional and new tools. Rev Soc Bras Med Trop. 2014 Mar-Apr; 47(2): 130-6. PubMed | Google Scholar

  33. Booth M, Vennervald BJ, Kabatereine NB et al. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans R Soc Trop Med Hyg. 2004; 98(2): 125-36. PubMed | Google Scholar

  34. Eltoum IA, Taha TE, Saad AM et al. Predictors of upper gastrointestinal bleeding in patients with schistosomal periportal fibrosis. British journal of surgery. 1994; 81(7): 996-9. PubMed | Google Scholar

  35. Elghuel A. The characteristics of adults with upper gastrointestinal bleeding admitted to Tripoli Medical Center: a retrospective case-series analysis. Libyan J Med. 2011 Mar 7; 6. PubMed | Google Scholar

  36. Ginn JL, Ducharme J. Recurrent bleeding in acute upper gastrointestinal hemorrhage: transfusion confusion. CJEM. 2001; 3(3): 193-8. PubMed | Google Scholar

  37. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014 Feb; 127(2): 124-131.e3. PubMed | Google Scholar

  38. Villanueva C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013 Jan 3; 368(1): 11-21. PubMed | Google Scholar

  39. Davidson RN, Houston S, Kiire CF. Schistosomal periportal fibrosis in Zimbabwe: use of ultrasound in patients with oesophageal varices. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1991; 85(3): 380–2. PubMed | Google Scholar

  40. Berzigotti A, Merkel C, Magalotti D et al. New abdominal collaterals at ultrasound: A clue of progression of portal hypertension. Digestive and Liver Disease. 2008; 40(1): 62–7. PubMed | Google Scholar

  41. Coutinho A. Hemodynamic studies of portal hypertension in schistosomiasis. The American journal of medicine. 1968; 44(4): 547-56. PubMed | Google Scholar

  42. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends in parasitology. 2005; 21(8): 386-92. PubMed | Google Scholar

  43. De Araújo Souza MR, de Toledo CF, Borges DR. Thrombocytemia as a predictor of portal hypertension in schistosomiasis. Digestive diseases and sciences. 2000; 45(10): 1964-70. PubMed | Google Scholar

  44. Andrade JR, Silva LD, Guimarães CM et al. Chronic hepatitis B and liver schistosomiasis: a deleterious association. Trans R Soc Trop Med Hyg. 2014; 108(3): 159-64. PubMed | Google Scholar

  45. Cai C-X, Xu X-F, Chen X-Q. Causes of death of advanced schistosomiasis patients in Jiaxing City from 1998 to 2008. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2012; 24(1): 88-90. PubMed | Google Scholar

  46. Srygley FD, Gerardo CJ, Tran T et al. Does this patient have a severe upper gastrointestinal bleed?. JAMA. 2012; 307(10): 1072-9. PubMed | Google Scholar

  47. Paley L, Zornitzki T, Cohen J et al. Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital. Archives of internal medicine. 2011; 171(15): 1393-400. PubMed | Google Scholar

  48. Redberg RF. The Value of History Taking in Diagnosis. Archives of internal medicine. 2011; 171(15): 1396. PubMed | Google Scholar

  49. Tabibian N, Graham DY. Source of upper gastrointestinal bleeding in patients with esophageal varices seen at endoscopy. J Clin Gastroenterol. 1987; 9(3): 279-82. PubMed | Google Scholar